FTSE 1008,245.30+0.42%indicative
UK 10Y Gilt4.52%+3bpindicative
UK 30Y Gilt4.89%+2bpindicative
EUR 10Y Bund2.68%-1bpindicative
GBP/EUR1.1642+0.12%indicative
GBP/USD1.2785-0.08%indicative
SONIA4.45%indicative
BoE Rate4.50%indicative
BPA 2026 YTD~£18bnindicative
FTSE 1008,245.30+0.42%indicative
UK 10Y Gilt4.52%+3bpindicative
UK 30Y Gilt4.89%+2bpindicative
EUR 10Y Bund2.68%-1bpindicative
GBP/EUR1.1642+0.12%indicative
GBP/USD1.2785-0.08%indicative
SONIA4.45%indicative
BoE Rate4.50%indicative
BPA 2026 YTD~£18bnindicative
FTSE 1008,245.30+0.42%indicative
UK 10Y Gilt4.52%+3bpindicative
UK 30Y Gilt4.89%+2bpindicative
EUR 10Y Bund2.68%-1bpindicative
GBP/EUR1.1642+0.12%indicative
GBP/USD1.2785-0.08%indicative
SONIA4.45%indicative
BoE Rate4.50%indicative
BPA 2026 YTD~£18bnindicative
Insurance Asset News
Regulation & Policy

HeroWear’s New Exoskeleton System Promises 62% Reduction in Workers’ Compensation Claims

26 January 2026·1 min read

Exoskeleton Innovation Promises to Transform Workers' Compensation Landscape This week, HeroWear, a company specializing in wearable technology, announced the successful deployment of its exoskeleton system, which has demonstrated a remarkable 62% reduction in back and strain injuries among workers. This development, stemming from research conducted by Vanderbilt University,…

Founding Member Access

This article continues with in-depth analysis. Start your free trial for full access to all articles, data tools, and intelligence briefings.

Free Trial — 6 Months

Already a member? Log in

Related Articles